10-Q Filing

GUARDANT HEALTH, INC. CIK: 1576280 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001576280-23-000123`
Period End Date	20230630
Filing Date	20230803
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	gh-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 84 Cash Flow Statement 94 Stockholders Equity 46 Comprehensive Income 20

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.65M	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$271.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$215.17M	USD	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$953.78M	USD	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$869.58M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$86.47M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$97.26M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory, net	`InventoryNet`	$51.60M	USD	Point-in-time
Inventory, net	`InventoryNet`	$60.53M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	102.62M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.66M	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$31.51M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$25.81M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.19B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	102.62M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.66M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.40B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$155.74M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$167.92M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$165.27M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$174.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$11.73M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.36M	USD	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$61.45M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$107.70M	USD	Point-in-time
Total Assets	`Assets`	$1.61B	USD	Point-in-time
Total Assets	`Assets`	$1.84B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$175.82M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$188.70M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$12.24M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$17.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$200.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$193.22M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.14B	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.14B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$198.23M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$210.01M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$9.18M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$9.45M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.55B	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.55B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of June 30, 2023, and December 31, 2022; 117,662,134 and 102,619,383 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of June 30, 2023, and December 31, 2022; 117,662,134 and 102,619,383 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.74B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.17B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.52M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.66B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.87B	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$645.00M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$292.73M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$60.18M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$533.04M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$319.09M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$-44.55M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.84B	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.61B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$176.20M	USD	2 Qtrs
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$92.06M	USD	1 Quarter
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$125.24M	USD	1 Quarter
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$238.64M	USD	2 Qtrs
Development services and other	`RevenueFromDevelopmentServices`	$27.23M	USD	2 Qtrs
Development services and other	`RevenueFromDevelopmentServices`	$17.08M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$11.91M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$29.05M	USD	2 Qtrs
Total revenue	`Revenues`	$137.15M	USD	1 Quarter
Total revenue	`Revenues`	$205.24M	USD	2 Qtrs
Total revenue	`Revenues`	$265.86M	USD	2 Qtrs
Total revenue	`Revenues`	$109.14M	USD	1 Quarter
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$34.38M	USD	1 Quarter
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$65.06M	USD	2 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$94.46M	USD	2 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$49.36M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$3.65M	USD	2 Qtrs
Cost of development services and other	`CostOfDevelopmentServices`	$12.46M	USD	2 Qtrs
Cost of development services and other	`CostOfDevelopmentServices`	$2.35M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$4.49M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$167.21M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$183.49M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$85.45M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$90.36M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$138.03M	USD	2 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$71.04M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$147.17M	USD	2 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$73.60M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$81.96M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$84.95M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$41.52M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$43.68M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$458.90M	USD	2 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$239.47M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$256.77M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$519.53M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-119.62M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-253.67M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-253.66M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-130.32M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.17M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.39M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.73M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$9.79M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.29M	USD	2 Qtrs
Interest expense	`InterestExpense`	$645.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$645.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.29M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$330.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$378.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$39.60M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$41.26M	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	2 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	$-99.78M	USD	2 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	$-99.78M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-228.99M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-352.24M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-72.28M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-205.57M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$446.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$736.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$496.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$422.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-72.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-352.66M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-206.30M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-229.43M	USD	1 Quarter
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-0.67	USD	1 Quarter
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-2.25	USD	1 Quarter
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-3.46	USD	2 Qtrs
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-1.95	USD	2 Qtrs
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-3.46	USD	2 Qtrs
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-0.67	USD	1 Quarter
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.95	USD	2 Qtrs
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-2.25	USD	1 Quarter
Weighted-average shares used in computing net loss per share , basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.05M	shares	1 Quarter
Weighted-average shares used in computing net loss per share , basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	108.81M	shares	1 Quarter
Weighted-average shares used in computing net loss per share , basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.75M	shares	2 Qtrs
Weighted-average shares used in computing net loss per share , basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.95M	shares	2 Qtrs
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.75M	shares	2 Qtrs
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.05M	shares	1 Quarter
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.95M	shares	2 Qtrs
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.81M	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-72.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-352.66M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-206.30M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-229.43M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.98M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.99M	USD	2 Qtrs
Operating lease costs	`NonCashOperatingLeaseCosts`	$14.71M	USD	2 Qtrs
Operating lease costs	`NonCashOperatingLeaseCosts`	$14.20M	USD	2 Qtrs
Contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$10.00K	USD	2 Qtrs
Contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$3.81M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$44.62M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$50.34M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.28M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.29M	USD	2 Qtrs
Amortization of (discount) premium on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$3.08M	USD	2 Qtrs
Amortization of (discount) premium on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.80M	USD	2 Qtrs
Unrealized gains on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	2 Qtrs
Unrealized gains on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$67.88M	USD	2 Qtrs
Impairment of non-marketable equity securities and other related assets	`OtherAssetImpairmentCharges`	-	USD	2 Qtrs
Impairment of non-marketable equity securities and other related assets	`OtherAssetImpairmentCharges`	$29.05M	USD	2 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	-	USD	2 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	$-99.78M	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-20.00K	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-98.00K	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-2.35M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-10.70M	USD	2 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$8.93M	USD	2 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$29.22M	USD	2 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$891.00K	USD	2 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-23.67M	USD	2 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$-4.30M	USD	2 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$-1.70M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities`	$16.51M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities`	$22.42M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-6.59M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-14.97M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-6.06M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$5.95M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-168.46M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-140.55M	USD	2 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$238.60M	USD	2 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$561.34M	USD	2 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$335.00M	USD	2 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$492.70M	USD	2 Qtrs
Purchase of non-marketable equity securities and other related assets	`PaymentsToAcquireEquitySecuritiesFvNi`	$12.75M	USD	2 Qtrs
Purchase of non-marketable equity securities and other related assets	`PaymentsToAcquireEquitySecuritiesFvNi`	$1.23M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.04M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.73M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-83.90M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$37.91M	USD	2 Qtrs
Payments made on finance lease obligations	`FinanceLeasePrincipalPayments`	$35.00K	USD	2 Qtrs
Payments made on finance lease obligations	`FinanceLeasePrincipalPayments`	$37.00K	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$220.00K	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.16M	USD	2 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$6.70M	USD	2 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$5.74M	USD	2 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.11M	USD	2 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.18M	USD	2 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	$177.78M	USD	2 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	-	USD	2 Qtrs
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	$381.40M	USD	Point-in-time
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	$402.50M	USD	2 Qtrs
Payment of offering costs related to follow-on public offering	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Payment of offering costs related to follow-on public offering	`PaymentsOfStockIssuanceCosts`	$21.27M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$383.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-172.10M	USD	2 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.42M	USD	2 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.21M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$129.23M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-276.95M	USD	2 Qtrs
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$271.17M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$215.34M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$271.17M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$215.34M	USD	Point-in-time
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$4.07M	USD	2 Qtrs
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.96M	USD	2 Qtrs
Purchase of property and equipment included in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$2.15M	USD	2 Qtrs
Purchase of property and equipment included in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$16.90M	USD	2 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	$9.69M	USD	2 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	-	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$271.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$215.17M	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$170.00K	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$101.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$271.17M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$215.34M	USD	Point-in-time

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Adjustments to additional paid in capital, stock issued, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$21.13M	USD	1 Quarter
Adjustments to additional paid in capital, stock issued, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$21.13M	USD	2 Qtrs
Adjustments to additional paid in capital, stock issued, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$21.10M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.73M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$60.18M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$533.04M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$319.09M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-44.55M	USD	Point-in-time
Issuance of common stock upon follow-on public offering, net of offering costs of (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	14.38M	shares	Point-in-time
Issuance of common stock upon follow-on public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$381.37M	USD	1 Quarter
Issuance of common stock upon follow-on public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$381.37M	USD	2 Qtrs
Issuance of common stock upon exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	31,879.00	shares	2 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$220.00K	USD	2 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.19M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$63.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.16M	USD	2 Qtrs
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$8.00K	USD	2 Qtrs
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.74M	USD	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$6.70M	USD	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.74M	USD	2 Qtrs
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$6.70M	USD	2 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.11M	USD	2 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.12M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.22M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.18M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$44.62M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$25.54M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.34M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$22.35M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-19.50M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$11.05M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.95M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$3.68M	USD	1 Quarter
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$9.83M	USD	2 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$9.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-352.66M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-206.30M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-229.43M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.73M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$60.18M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$533.04M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$319.09M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-44.55M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-72.77M	USD	1 Quarter
Net loss	`ProfitLoss`	$-206.30M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-229.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-352.66M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.93M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.53M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-17.29M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.47M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.21M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.42M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.25M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.42M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-19.50M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$11.05M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.95M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$3.68M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-195.25M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-372.16M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-69.09M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-235.38M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.